Categorization and complication of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease is the most prevalent with a global prevalence of 25%. The frequency non-alcoholic and percentage people severe are expected to rise given ongoing obesity pandemic, in diabetes, other factors. This will have significant effect on health care expenditure need for transplantation, which steatohepatitis already track overtake alcoholic as reason. characterized by triglyceride accumulation cytoplasm hepatocytes. Patients who advanced fibrosis at much higher risk negative outcomes, such overall mortality liver-specific morbidity death. It multisystemic clinical illness entity that manifests extrahepatic conditions like polycystic ovarian syndrome, type 2 chronic renal disease, hypothyroidism, psoriasis. In fact, cardiovascular cancer, liver-related problems three leading causes death patients, order. further divided into two subtypes hepatic steatosis ranging from milder more aggressive form disease.